Supply Notification: H2-antagonists (Cimetidine, Famotidine and Nizatidine) – Update

Update (18/03/2021): resupply dates now expected:

Product Supplier Current Stock Position Anticipated Resupply date Detail
Famotidine 20mg tablets Tilomed Laboratories In stock n/a
Teva UK Out of stock May 2021
Famotidine 40mg tablets Tilomed Laboratories In stock n/a
Teva UK Out of stock June 2021
Cimetidine 200mg tablets Ennogen Pharma Out of stock June 2021 Unlicensed supplies have been sourced
Medreich Out of stock to be confirmed
Cimetidine 400mg tablets Ennogen Pharma Out of stock June 2021
Medreich Out of stock to be confirmed
Cimetidine 800mg tablets Ennogen Pharma Out of stock June 2021
Medreich Out of stock to be confirmed
Cimetidine 200mg/5ml oral solution Rosemont Pharmaceuticals In stock w/c 5 April 2021
Cimetidine (Tagamet) 200mg/5ml syrup Essential Pharma In stock n/a
Nizatidine 150mg capsules Viatris (Mylan) Out of stock to be confirmed
Medreich Out of stock to be confirmed
Relonchem In stock n/a
Nizatidine 300mg capsules  Viatris (Mylan) Out of stock to be confirmed
Medreich Out of stock to be confirmed
Relonchem In stock n/a

The following specialist importers have confirmed they can source unlicensed cimetidine tablets (please note, there may be other companies that can also source supplies):

If there is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems an EPS prescription for unlicensed Cimetidine (strength) tablets cannot be issued. Where a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Cimetidine (strength) tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

 

Department of Health and Social Care (DHSC) has issued a medicine supply notification for H2-antagonists (Cimetidine, Famotidine and Nizatidine)

Suppliers of Cimetidine, Famotidine and Nizatidine have reported an increase in demand, which has contributed to short term shortages of Cimetidine 200mg tablets, Famotidine 20mg tablets, and Nizatidine 150mg and 300mg tablets.

  • Famotidine 20mg tablets are out of stock until the end of December 2019.
  • Cimetidine 200mg tablets are out of stock until the end of January 2020.
  • Nizatidine 150mg and 300mg tablets are out of stock until February 2020.

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

Discover how we are working to improve the outlook for community pharmacy at an event near you.

Click Here